Global Viral Detection Market Size, Share, and Trends Analysis Report, By Method (Plaque Assays, Polymerase Chain Reaction (PCR), ELISA, and Others) and By Application (Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products, and Vaccine & Therapeutics), Forecast (2022-2028)

The global viral detection market is anticipated to grow at a considerable CAGR 5% during the forecast period (2022-2028). Viral detection is the process of testing and finding out the disease-causing virus in several items and processes including blood, tissues, vaccines, and others. The major factor attributing to the growth of the global viral detection market includes the application of viral detection in blood products of blood banks, including whole blood, red blood cells, platelets, plasma, cyro, white blood cells, and others as the number of blood donations and blood transfusion across the globe is increasing. According to the report published by the World Health Organization (WHO) in June 2020, around 118.4 million blood donations are collected across the globe that goes throw viral detection. Additionally, the increasing need for blood product transfusion is also increasing the application of viral detection. According to the Americal National Red Cross (ANRC), around 29,000 units of blood, around 5,000 units of platelets, and around 6,500 units of plasma are required every day in the US. It is estimated that around 16 million blood components are transfused every year in the US.

The application of viral detection in stem cell products, including pluripotent stem cells, mesenchymal stem cells, neural stem cells, hematopoietic stem cells, cancer stem cells, and others that are used in the treatment of patients with immunity disorders and cancer, is also increasing. According to the report published by the WHO in February 2022, cancer is the major cause of mortality globally with around 10 million mortality caused due to cancer in 2020. The most common type of cancers includes breast, lung, colon and rectum, prostate, and skin cancer. Thus, contributing to the growth of the global viral detection market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Method
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Merck & Co. Inc., Merck Group, Lonza Group Ltd., Texcell Inc., and Charles River Laboratories International Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Viral Detection  Market Report by Segment

By Method

• Plaque Assays
• Polymerase Chain Reaction (PCR)
• ELISA
• Others

By Application

• Blood & Blood Products
• Cellular & Gene Therapy Products
• Stem Cell Products
• Tissue & Tissue Products
• Vaccine & Therapeutics